Community-Engaged Research: COVID-19 Testing, Infection, and Vaccination among Underserved Minority Communities in Miami, Florida.
Haley R MartinDavid R BrownEileen FluneyMary Jo TrepkaAileen M MartyEneida O RoldanQingyun LiuManuel A BarbieriMarianna K BaumPublished in: Vaccines (2024)
Community collaboration is a cornerstone of modern public health efforts. This work aimed to use community-engaged research to explore COVID-19 vaccination, testing, and infection in a minoritized community. This study was conducted in Miami, Florida, from March 2021 to February 2022 in community partner sites and the Miami Adult Studies on HIV (MASH) cohort. Sociodemographic characteristics, vaccination and testing beliefs, and COVID-19 challenges were self-reported. COVID-19 vaccinations were verified with medical records, testing history was self-reported, and severe acute respiratory syndrome coronavirus 2 positivity was determined via real-time reverse transcription-polymerase chain reaction (rt-PCR). Of 1689 participants, the median age was 57, 51% were male, 49% were non-Hispanic Black, 66% reported an income < USD 15,000/year, and 75.9% received at least one dose of a COVID-19 vaccine. Belief that COVID-19 vaccination is effective was associated with lower odds of COVID-19 positivity and was the strongest predictor of vaccination. Challenges accessing health care, housing, food, and transportation were associated with lower odds of vaccination. Employment, health insurance, higher education, and greater perceived test accuracy were associated with greater odds of COVID-19 testing. Social determinants of health and the belief that vaccines are effective and tests are accurate predicted behaviors and thus should be considered during public health crises in vulnerable communities.
Keyphrases
- coronavirus disease
- sars cov
- healthcare
- respiratory syndrome coronavirus
- public health
- mental health
- health insurance
- physical activity
- high resolution
- risk assessment
- health information
- quality improvement
- human immunodeficiency virus
- antiretroviral therapy
- hepatitis c virus
- climate change
- hiv infected
- south africa
- affordable care act
- real time pcr